Login to your account

Username *
Password *
Remember Me
Lab study found CoronaVac serum neutralization efficiency was significantly decreased against B.1.526, P.1, and B1.351 SARS-CoV-2 variants.

Lab study found CoronaVac serum neutralization efficiency was significantly decreased against B.1.526, P.1, and B1.351 SARS-CoV-2 variants.

Bibliographie
28 mai 2021
Soyez le premier à commenter!

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac – The Lancet Infectious Diseases  

The post Lab study found CoronaVac serum neutralization efficiency was significantly decreased against B.1.526, P.1, and B1.351 SARS-CoV-2 variants. appeared first on Links Medicus.

Lu 631 fois
Évaluer cet élément
(0 Votes)
Plus dans cette catégorie : « COLCORONA RCT: Colchicine for community-treated patients with COVID-19 – findings suggest it may lower death and hospital admission rates, but further studies are required. RCT: Pfizer-BioNTech Covid-19 vaccine shows 100% efficacy in adolescents – mainly transient mild-to-moderate reactogenicity was frequently observed, such as injection-site pain (in 79 to 86% of participants), fatigue (in 60 to 66%), and headache (in 55 to »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.

Retour en haut

Search